‌

US Patent 10759864 Anti-human transferrin receptor antibody capable of penetrating blood-brain barrier

Patent 10759864 was granted and assigned to JCR Pharmaceuticals on September, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

JCR Pharmaceuticals

Current Assignee

JCR Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10759864

Date of Patent

September 1, 2020

Patent Application Number

16473446

Date Filed

December 26, 2017

Patent Citations Received

‌

US Patent 11912778 Methods of engineering transferrin receptor binding polypeptides

Patent Primary Examiner

‌

Adam Weidner

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10759864 Anti-human transferrin receptor antibody capable of penetrating blood-brain barrier

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API